Immunovant (IMVT) Exchange Rate Effect (2021 - 2026)
Immunovant's (IMVT) quarterly Exchange Rate Effect came in at -$988000.0 in Q1 2026, down 102.46% YoY from $40.2 million in Q1 2025, and down 362.07% on a QoQ basis from $377000.0 in Q4 2025.
Powered by 
Analysis
Immunovant (IMVT) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Immunovant (IMVT) has 6 years of Exchange Rate Effect data on file, last reported at -$988000.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 102.46% year-over-year to -$988000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$299000.0 (down 140.03% YoY) and the FY2026 annual result came in at -$299000.0, down 140.03% from the prior year.
- Exchange Rate Effect slipped to -$988000.0 in Q1 2026, from $377000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $2.7 million in Q1 2024 to a low of -$1.6 million in Q4 2023.
- A 5-year average of $91117.6 and a median of -$112000.0 in 2022 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect soared 13385.0% — and 2023, when it slumped 337.5%.
- Tracing IMVT's Exchange Rate Effect over 5 years: stood at $2.7 million in 2022, then plunged by 159.55% to -$1.6 million in 2023, then surged by 90.72% to -$149000.0 in 2024, then surged by 353.02% to $377000.0 in 2025, then plunged by 362.07% to -$988000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$988000.0 (Q1 2026), $377000.0 (Q4 2025), and $878000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Immunovant | 8.07 Bn | 8.07 Bn | - | -4,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4,000.00 |
| Mar 31, 2026 | -988,000.00 |
| Dec 31, 2025 | 377,000.00 |
| Sep 30, 2025 | 878,000.00 |
| Jun 30, 2025 | -566,000.00 |
| Mar 31, 2025 | -488,000.00 |
| Dec 31, 2024 | -149,000.00 |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 335,000.00 |
| Mar 31, 2024 | 2.73 Mn |
| Dec 31, 2023 | -1.61 Mn |
| Sep 30, 2023 | -86,000.00 |
| Jun 30, 2023 | -47,000.00 |
| Mar 31, 2023 | -490,000.00 |
| Dec 31, 2022 | 2.70 Mn |
| Sep 30, 2022 | -1.22 Mn |
| Jun 30, 2022 | -772,000.00 |
| Mar 31, 2022 | -112,000.00 |
| Dec 31, 2021 | 20,000.00 |